What your legs are quietly telling you about your health, a vascular surgeon explains

Leg swelling, cold feet, numbness or night cramps may be more than everyday discomfort. Vascular experts explain five leg ...
Targeted Oncology

Quadruplet Regimen With Penpulimab and Anlotinib Extends PFS in Metastatic Pancreatic Cancer

The PAAG regimen significantly improved PFS and response rates in metastatic pancreatic cancer compared to chemotherapy alone ...
Dynamite News

Cold feet even with socks on? 8 reasons you shouldn’t ignore

Cold feet even with socks on? Persistent chilly toes could signal circulation problems, diabetes, thyroid issues, or stress.
Oncology Nursing News

Zanidatamab/Chemo ± Tislelizumab Shows Frontline SOC Promise in GEA

The frontline combination of zanidatamab-hrii (Ziihera) and chemotherapy with or without tislelizumab (Tevimbra) was ...
Mirage News

Pfizer's BRAFTOVI Boosts Response in Metastatic CRC

Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating ...
Le Lézard

Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...

MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis

MapLight Therapeutics, Inc. (“MapLight”) (Nasdaq: MPLT) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ML-007C-MA, an investigational novel ...
Le Lézard

RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer

Johnson & Johnson today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal growth factor ...